Investigate Risperidone for the Treatment of Schizophrenia in Adolescents
Clinical trial NCT00088075 · COMPLETED
Trial details
- NCT number
- NCT00088075
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.